NAV Loans in Private Equity: How GPs Borrow Against Fund Portfolios to Pay LPs

By Jeff Barnes, MBA | Angel Investors Network | August 3, 2026

TL;DR: NAV loans let private equity general partners borrow against the net asset value of a fund's existing portfolio without selling a single company. Lenders take a security interest in LP interests or portfolio distributions. The market hit roughly $44 billion in 2023 deal flow and S&P Global estimates $150 billion outstanding as of 2024. For LPs, NAV loans can accelerate returns or fund growth. They also add a layer of debt on top of assets that already carry significant leverage.

What Is a NAV Loan?

A NAV loan is a credit facility secured against the net asset value of a private equity fund's portfolio. The borrower is the fund itself, or a holding entity set up by the GP. The lender takes a security interest in the LP interests, the distributions flowing from portfolio companies, or both.

The mechanics work like this. A fund holds a dozen portfolio companies valued at $2 billion in aggregate. A NAV lender extends a facility, often 15% to 25% of that portfolio value, so somewhere in the $300 million to $500 million range. The loan is not secured by the equity in any single company. It is secured by the blended value of the whole pool. Diversification is the buffer.

That buffer matters. Analysis from Alpha Match shows NAV facilities can withstand a 36% to 47% decline in portfolio value before hitting a covenant breach. That is a meaningful cushion, but it is not unlimited. A sharp market dislocation or a cluster of write-downs can erode it fast.

NAV loans are distinct from subscription credit lines, which are secured by unfunded LP capital commitments. Subscription lines sit at the front end of a fund's life. NAV loans sit at the back end, used when the fund is mostly invested and LP commitments have already been drawn. They are increasingly common as hold periods stretch and the secondaries market sees record activity in 2026.

The Money-In vs. Money-Out Distinction and Why It Matters for LPs

Not all NAV loans serve the same purpose. The industry draws a clear line between two uses: money-in and money-out.

Money-in NAV loans put capital back to work inside the fund. The GP borrows against existing portfolio value to fund add-on acquisitions, support a company through a downturn, or extend the hold period while waiting for a better exit environment. According to a survey by 17Capital, 89% of existing NAV loan balances fall into this category. The logic is straightforward: the GP sees more value to extract but needs dry powder to get there.

Money-out NAV loans do the opposite. The GP borrows against the portfolio and distributes the proceeds to LPs, returning capital without selling anything. This is where LP sentiment has turned sharply negative.

In H1 2023, money-out usage was common as GPs scrambled to show return of capital in a slow exit environment. By H2 2023, it fell roughly 90% as LP pushback intensified. A 17Capital LP survey found 62% of LPs now oppose money-out NAV lending, against 38% who remain in favor. The core objection: LPs are receiving what looks like a distribution, but the underlying assets have not been sold. The fund has simply borrowed against them. If those assets later lose value, the loan still has to be repaid, and that repayment comes from the same pool of assets that was supposed to generate LP returns.

Think of it this way. If a fund borrows $200 million against a $1 billion portfolio and distributes that $200 million to LPs, each LP gets cash today. But the fund now carries a $200 million liability. The net NAV available to those same LPs has not grown; it has shrunk by the amount of the outstanding loan plus interest costs. LPs are receiving their own money back, with a debt load attached.

This dynamic connects to a broader conversation about how fund economics affect LP net returns, including how management fee structures interact with distributions. When borrowing replaces sales as the source of distributions, the fee clock keeps running while the exit risk stays with the fund.

The Providers and Typical Deal Terms

The NAV lending market has attracted a distinct set of capital providers, and the mix tells you something about where this product sits in the credit spectrum.

17Capital is the largest dedicated NAV lender globally, with a focus on the mid-market. Oaktree Capital has built out a significant NAV finance business; their public primer, NAV Finance 101, is the clearest plain-language explanation of the product available. Goldman Sachs, HSBC, Ares Management, and Pemberton Asset Management are also active. The entry of large bank balance sheets and established credit managers signals that this is no longer a niche product.

On deal terms, typical structures look like this:

• Advance rate: 15% to 25% of portfolio NAV, though some senior lenders go higher on concentrated, high-quality portfolios.
• Tenor: Two to five years, often aligned with the fund's expected wind-down timeline.
• Pricing: Floating rate, typically SOFR plus 300 to 600 basis points depending on portfolio quality, concentration, and loan-to-value ratio.
• Covenants: NAV maintenance tests, loan-to-value triggers, and concentration limits by portfolio company or sector.
• Security: Pledge of LP interests, assignment of distribution proceeds, or direct charge over fund assets depending on jurisdiction and fund structure.

The NAV finance market is forecast to reach $145 billion by 2030, per a 17Capital and Preqin base-case projection. That would represent roughly a tripling from estimated 2024 outstanding balances. A Proskauer survey of fund finance market participants found about 80% of respondents expect NAV financing volumes to increase in 2026. The product is growing, and the GP and LP communities are still negotiating the norms around it.

The LP Concern: Leverage on Already-Leveraged Assets

The standard LP objection to NAV loans is layered debt. Private equity portfolio companies already carry significant leverage. That is part of the buyout model. Adding a NAV loan at the fund level puts a second layer of debt on top of assets that are already highly leveraged at the company level.

In a benign exit environment, this does not create problems. Companies sell at good multiples, fund NAV holds up, and the loan gets repaid out of proceeds. The GP and LPs share the upside. In a stressed environment, the math turns ugly. If several portfolio companies face earnings pressure at the same time, NAV drops. The fund may trigger loan-to-value covenants. The lender can demand additional collateral or accelerate repayment. The GP may be forced to sell assets at distressed valuations, which is precisely the scenario LPs fear most.

The counter-argument from GPs and lenders has two parts. First, most NAV loans are money-in, not money-out. Borrowing to fund add-ons or support portfolio companies is economically similar to a company drawing a revolver. It is tactical liquidity, not financial engineering. Second, the diversification of a fund portfolio provides real protection. A lender holding security over 12 companies is not exposed to any single blow-up the way a senior lender to one company is.

Both points have merit. The first collapses if the add-on acquisitions do not perform. The second holds until correlation spikes, which tends to happen in the same market environments where fund NAV is already under pressure.

Investors exploring this product alongside other fund structures should understand how it interacts with liquidity features in other vehicles. A comparison of interval funds versus closed-end fund structures illustrates how differently liquidity and leverage risk can be packaged for end investors.

How NAV Loans Affect LP Returns: The Math on Distribution Timing vs. Risk

The return math on NAV loans depends entirely on what the borrowed capital does next.

Take a fund with $1 billion in NAV, a 7-year hold period already elapsed, and a target 2.0x net multiple on invested capital. The GP takes out a $200 million NAV loan at SOFR plus 450 basis points, call it roughly 9.5% all-in. That $200 million either goes to LPs as a distribution or funds a $200 million add-on acquisition.

In the money-out scenario, LPs receive $200 million today. If the underlying portfolio returns $800 million net of the loan repayment and interest, the total LP return is $1 billion, the same as if no NAV loan had been taken. The timing benefit is real: getting $200 million two years early improves IRR because of the time value of money. But if the portfolio underperforms and returns only $700 million net of loan costs, LPs are worse off than they would have been without the loan. The GP has transferred exit risk from time to leverage.

In the money-in scenario, the GP deploys $200 million into an add-on that generates a 2.5x gross return, yielding $500 million of proceeds. After repaying the $200 million loan and interest costs of roughly $20 million (assuming a two-year hold), the fund nets $280 million incremental. That is a strong outcome and clearly accretive to LP returns. But it requires the add-on to perform. If the add-on returns 1.0x, the fund spent $20 million in interest to break even. If it returns below par, NAV has been destroyed and the loan still has to be repaid.

The analytical question for LPs is not whether NAV loans are good or bad. The question is whether the GP's proposed use of the facility is accretive at a level of confidence that justifies the additional risk. Money-in NAV loans that fund genuine value creation can improve net returns. Money-out NAV loans that substitute for exits can erode them, particularly when interest costs are running at 9% or above and portfolio company performance is uncertain.

LPs reviewing fund documents should look for NAV borrowing permissions in the limited partnership agreement. Many older LPAs do not explicitly authorize fund-level NAV borrowing, which is why some GPs are seeking LP consent through side letters or LP advisory committee approvals. That negotiation is an indicator of how contentious the product remains even as market volume grows.

The S&P Global estimate of $150 billion in outstanding NAV loans as of 2024 reflects a market that grew roughly 30% annually from 2019 through 2023. With forecast growth to $145 billion in new deal flow by 2030, NAV lending is becoming a standard tool in the GP toolkit. For LPs, the work is understanding exactly how each facility is structured, what the GP intends to do with the proceeds, and how the loan ranks against LP interests in the fund's waterfall. Those details are in the documents. Read them.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.